mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.08 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.08 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.08 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.09 |
0.09 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |